SCHEMBL6375747

SCHEMBL6375747

O=C(Nc1ccc(Cl)cc1)NC(C(=O)Nc1ccc(N2CCCCC2)cc1)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.64
NPC1 O15118 2/20 0.64
MAPT P10636 8/20 0.62
GAA P10253 2/20 0.62
KDM4E B2RXH2 1/20 0.62
KMT2A Q03164 2/20 0.61
NPSR1 Q6W5P4 2/20 0.61
USP2 O75604 1/20 0.61
ESR1 P03372 1/20 0.61
NR4A1 P22736 1/20 0.61
PTK2B Q14289 1/20 0.61
EP300 Q09472 2/20 0.56
KCNQ2 O43526 1/20 0.56
CNR1 P21554 6/20 0.54
GFER P55789 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.51
RAB9A P51151 2/20 0.51
TP53 P04637 1/20 0.51
PKM P14618 1/20 0.51
NFKB1 P19838 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6375742 1.00 ALDH1A1 (0.64) ALDH1A1NPC1MAPTGAAKDM4E
SCHEMBL5429259 0.84 F10 (0.59) ALDH1A1NPC1MAPTGAAKDM4E
SCHEMBL6372830 0.84 F10 (0.59) ALDH1A1NPC1MAPTGAAKDM4E
SCHEMBL5631599 0.83 F10 (0.49) ALDH1A1NPC1MAPTGAAKDM4E
SCHEMBL5632127 0.83 F10 (0.49) ALDH1A1NPC1MAPTGAAKDM4E
SCHEMBL5631123 0.82 F10 (0.47) ALDH1A1NPC1MAPTGAAKDM4E
SCHEMBL5630997 0.82 F10 (0.47) ALDH1A1NPC1MAPTGAAKDM4E
SCHEMBL5346289 0.82 EP300 (0.48) ALDH1A1NPC1MAPTGAAKDM4E
SCHEMBL6374295 0.82 CNR1 (0.56) ALDH1A1NPC1MAPTGAAKDM4E
SCHEMBL8264405 0.82 ALDH1A1 (0.47) ALDH1A1NPC1MAPTGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050137230-A1 Carboxamide derivatives DORSCH DIETER (DE) 2005-06-23 US claimed
US-20040038858-A1 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours MERCK PATENT GMBH (DE) 2004-02-26 US claimed
US-20050137230-A1 Carboxamide derivatives DORSCH DIETER (DE) 2005-06-23 US disclosed
US-20040038858-A1 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours MERCK PATENT GMBH (DE) 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137230-A1 Carboxamide derivatives F11, F12, F2 ALDH1A1 832/4885NPC1 2780/4885MAPT 4846/4885
US-20040038858-A1 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours CNR2, CNR1, HCAR2 ALDH1A1 1757/4885NPC1 3419/4885MAPT 4879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.